|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Goodwill impairment | |||||
| Operating income | |||||
| Interest expense | |||||
| Equity method income | |||||
| Remeasurement gain on acquisition of equity method investee | |||||
| Other income (expense), net | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) attributable to noncontrolling interest | |||||
| Net income (loss) attributable to Mission Produce | |||||
| Net income (loss) per share attributable to Mission Produce: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive income | |||||
Loading...